Specifically, identified literature demonstrates that mood stabilizer valproic acid reduces CRY2 expression in the amygdala (Ogden et al., 2004), suggesting the involvement of such clock genes in mood disorders (Liberman et al., 2018) and the potential to manipulate this pathway with CR mimetics. This evidence concerns the gene CLOCK and mood disorder.